At United BioChannels we deliver the strategy and support required for our Brands and their investors to bring innovations to market.
Brand awareness within the life science ecosystem targeting researchers, pharmaceutical companies, and investors.
Rapid revenue growth utilizing established agent channels and regional business development consultants.
Business forecasting, channel transparency, and regular business review.
“United BioChannels enables me to stay focused on providing excellent customer service. Their brands offer value to my clients by providing cutting edge technology, the technical resources to apply it and commercial support consistent with a National sales office.”
– Vijay Bhakta, Manufacturer’s Representative
“UBC provided a network of skilled business development representatives helping us expand our reach into North American. Their market knowledge, familiarity with the US sales process and direct working knowledge of our key customers accelerated our sales under an affordable structure.”
– Iain McWilliam, PhD, CEO, Arrayjet Ltd
UBC specializes in developing and implementing proven marketing and sales strategies for life science companies
News and Resources
ThalesNano, a leading provider of flow chemistry instrumentation, is now represented by United BioChannels in North America
United BioChannels (UBC) is excited to announce that we have partnered with ThalesNano to enhance their commercial activities, including customer support for their products in North America. UBC specializes in the development and implementation of proven marketing and...
As part of their Series C financing, Biodesy has dedicated funds to expanding commercial efforts. Over the last four months the company has partnered with United BioChannels, a life science brand management company, to explore applications and customer...
Nanomedical Diagnostics Agile R100 Graphene Biosensor Characterizes Difficult-to-Study MYC Oncoprotein for Cancer Research
Using data gathered by Agile R100, a kinetic binding assay system, scientists from Dr. Kim Janda’s laboratory at the Scripps Research Institute developed a new series of compounds with the potential to down-regulate the transcriptional activities of MYC....